560 related articles for article (PubMed ID: 23824421)
1. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy.
Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421
[TBL] [Abstract][Full Text] [Related]
2. Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study.
Laforêt P; Stojkovic T; Bassez G; Carlier PG; Clément K; Wahbi K; Petit FM; Eymard B; Carlier RY
Mol Genet Metab; 2013 Feb; 108(2):125-31. PubMed ID: 23333026
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
[TBL] [Abstract][Full Text] [Related]
4. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM.
Tavian D; Missaglia S; Castagnetta M; Degiorgio D; Pennisi EM; Coleman RA; Dell'Era P; Mora C; Angelini C; Coviello DA
Mol Genet Metab; 2017 May; 121(1):28-34. PubMed ID: 28391974
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI in neutral lipid storage disease with myopathy carrying mutation c.187+1G>A.
Xu C; Zhao Y; Liu J; Zhang W; Wang Z; Yuan Y
Muscle Nerve; 2015 Jun; 51(6):922-7. PubMed ID: 25363365
[TBL] [Abstract][Full Text] [Related]
7. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
8. Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.
Missaglia S; Maggi L; Mora M; Gibertini S; Blasevich F; Agostoni P; Moro L; Cassandrini D; Santorelli FM; Gerevini S; Tavian D
Neuromuscul Disord; 2017 May; 27(5):481-486. PubMed ID: 28258942
[TBL] [Abstract][Full Text] [Related]
9. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets.
Kobayashi K; Inoguchi T; Maeda Y; Nakashima N; Kuwano A; Eto E; Ueno N; Sasaki S; Sawada F; Fujii M; Matoba Y; Sumiyoshi S; Kawate H; Takayanagi R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2877-84. PubMed ID: 18445677
[TBL] [Abstract][Full Text] [Related]
10. Fasting, but not exercise, increases adipose triglyceride lipase (ATGL) protein and reduces G(0)/G(1) switch gene 2 (G0S2) protein and mRNA content in human adipose tissue.
Nielsen TS; Vendelbo MH; Jessen N; Pedersen SB; Jørgensen JO; Lund S; Møller N
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1293-7. PubMed ID: 21613358
[TBL] [Abstract][Full Text] [Related]
11. Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.
Tan J; Yang H; Fan J; Fan Y; Xiao F
Clin Neurol Neurosurg; 2018 May; 168():102-107. PubMed ID: 29539587
[TBL] [Abstract][Full Text] [Related]
12. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
van der Zijl NJ; Goossens GH; Moors CC; van Raalte DH; Muskiet MH; Pouwels PJ; Blaak EE; Diamant M
J Clin Endocrinol Metab; 2011 Feb; 96(2):459-67. PubMed ID: 21084401
[TBL] [Abstract][Full Text] [Related]
13. The role of adipose triglyceride lipase in lipid and glucose homeostasis: lessons from transgenic mice.
Trites MJ; Clugston RD
Lipids Health Dis; 2019 Nov; 18(1):204. PubMed ID: 31757217
[TBL] [Abstract][Full Text] [Related]
14. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity.
Gan SK; Kriketos AD; Poynten AM; Furler SM; Thompson CH; Kraegen EW; Campbell LV; Chisholm DJ
Obes Res; 2003 Nov; 11(11):1295-305. PubMed ID: 14627749
[TBL] [Abstract][Full Text] [Related]
15. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
[TBL] [Abstract][Full Text] [Related]
17. Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy.
Hong D; Zheng J; Xin L; Xiang Y; Luan X; Cao L; Cong L; Fang P; Zhang J
Clin Neuropathol; 2019; 38(4):157-167. PubMed ID: 30738494
[TBL] [Abstract][Full Text] [Related]
18. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
[TBL] [Abstract][Full Text] [Related]
19. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
20. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation.
Hoy AJ; Bruce CR; Turpin SM; Morris AJ; Febbraio MA; Watt MJ
Endocrinology; 2011 Jan; 152(1):48-58. PubMed ID: 21106876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
